Resetting the Immune System may halt Multiple Sclerosis progression

Jun-10
 

High Dose immunosuppressive therapy with autologous hematopoietic cell transplant has been found to be a promising tool to stop the progression of MS in patients with early stage RRMS. In this treatment, a patient’s hematopoietic stem cells (HSCs)—precursor cells that develop into blood cells—are collected. High-dose chemotherapy and other drugs are then used to deplete the patient’s immune system. 

Read More >>